438 related articles for article (PubMed ID: 21406405)
81. USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma.
Eichhorn PJ; Rodón L; Gonzàlez-Juncà A; Dirac A; Gili M; Martínez-Sáez E; Aura C; Barba I; Peg V; Prat A; Cuartas I; Jimenez J; García-Dorado D; Sahuquillo J; Bernards R; Baselga J; Seoane J
Nat Med; 2012 Feb; 18(3):429-35. PubMed ID: 22344298
[TBL] [Abstract][Full Text] [Related]
82. Nucleolin promotes TGF-β signaling initiation via TGF-β receptor I in glioblastoma.
Lv S; Zhang J; Han M; Wang W; Zhang Y; Zhuang D; Shi R; Bian R; Yao C
J Mol Neurosci; 2015 Jan; 55(1):1-6. PubMed ID: 24682943
[TBL] [Abstract][Full Text] [Related]
83. A tumor-promoting role for soluble TβRIII in glioblastoma.
Burghardt I; Schroeder JJ; Weiss T; Gramatzki D; Weller M
Mol Cell Biochem; 2021 Aug; 476(8):2963-2973. PubMed ID: 33772427
[TBL] [Abstract][Full Text] [Related]
84. Identification of the proliferative effect of Smad2 and 3 in the TGF β2/Smad signaling pathway using RNA interference in a glioma cell line.
Dong C; Mi R; Jin G; Zhou Y; Zhang J; Liu F
Mol Med Rep; 2015 Aug; 12(2):1824-8. PubMed ID: 25891822
[TBL] [Abstract][Full Text] [Related]
85. Osimertinib successfully combats EGFR-negative glioblastoma cells by inhibiting the MAPK pathway.
Chen C; Cheng CD; Wu H; Wang ZW; Wang L; Jiang ZR; Wang AL; Hu C; Dong YF; Niu WX; Qi S; Qi ZP; Liu J; Wang WC; Niu CS; Liu QS
Acta Pharmacol Sin; 2021 Jan; 42(1):108-114. PubMed ID: 32398685
[TBL] [Abstract][Full Text] [Related]
86. Regulatory effects of a Mnk2-eIF4E feedback loop during mTORC1 targeting of human medulloblastoma cells.
Eckerdt F; Beauchamp E; Bell J; Iqbal A; Su B; Fukunaga R; Lulla RR; Goldman S; Platanias LC
Oncotarget; 2014 Sep; 5(18):8442-51. PubMed ID: 25193863
[TBL] [Abstract][Full Text] [Related]
87. TGF-β/Smad2/3 signal pathway involves in U251 cell proliferation and apoptosis.
Zhao HW; Li YW; Feng R; Yu JB; Li J; Zhang Y; Li JC; Wang YX
Gene; 2015 May; 562(1):76-82. PubMed ID: 25701598
[TBL] [Abstract][Full Text] [Related]
88. ShRNA-targeted MAP4K4 inhibits hepatocellular carcinoma growth.
Liu AW; Cai J; Zhao XL; Jiang TH; He TF; Fu HQ; Zhu MH; Zhang SH
Clin Cancer Res; 2011 Feb; 17(4):710-20. PubMed ID: 21196414
[TBL] [Abstract][Full Text] [Related]
89. Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma.
Seystahl K; Tritschler I; Szabo E; Tabatabai G; Weller M
Neuro Oncol; 2015 Feb; 17(2):254-65. PubMed ID: 25165192
[TBL] [Abstract][Full Text] [Related]
90. Nuclear SMAD2 restrains proliferation of glioblastoma.
Yu Y; Ran Q
Cell Physiol Biochem; 2015; 35(5):1756-63. PubMed ID: 25832460
[TBL] [Abstract][Full Text] [Related]
91. Direct inhibition of the transforming growth factor-β pathway by protein-bound polysaccharide through inactivation of Smad2 signaling.
Ono Y; Hayashida T; Konagai A; Okazaki H; Miyao K; Kawachi S; Tanabe M; Shinoda M; Jinno H; Hasegawa H; Kitajima M; Kitagawa Y
Cancer Sci; 2012 Feb; 103(2):317-24. PubMed ID: 22034928
[TBL] [Abstract][Full Text] [Related]
92. β-elemene inhibits proliferation of human glioblastoma cells through the activation of glia maturation factor β and induces sensitization to cisplatin.
Zhu T; Xu Y; Dong B; Zhang J; Wei Z; Xu Y; Yao Y
Oncol Rep; 2011 Aug; 26(2):405-13. PubMed ID: 21519795
[TBL] [Abstract][Full Text] [Related]
93. Design, synthesis and biological evaluation of 4-aniline-thieno[2,3-d]pyrimidine derivatives as MNK1 inhibitors against renal cell carcinoma and nasopharyngeal carcinoma.
Zhang M; Jiang L; Tao J; Pan Z; He M; Su D; He G; Jiang Q
Bioorg Med Chem; 2019 Jun; 27(11):2268-2279. PubMed ID: 31014565
[TBL] [Abstract][Full Text] [Related]
94. Combination of a ptgs2 inhibitor and an epidermal growth factor receptor-signaling inhibitor prevents tumorigenesis of oligodendrocyte lineage-derived glioma-initiating cells.
Hide T; Takezaki T; Nakatani Y; Nakamura H; Kuratsu J; Kondo T
Stem Cells; 2011 Apr; 29(4):590-9. PubMed ID: 21360625
[TBL] [Abstract][Full Text] [Related]
95. Elevated levels of p-Mnk1, p-eIF4E and p-p70S6K proteins are associated with tumor recurrence and poor prognosis in astrocytomas.
Fan W; Wang W; Mao X; Chu S; Feng J; Xiao D; Zhou J; Fan S
J Neurooncol; 2017 Feb; 131(3):485-493. PubMed ID: 27900644
[TBL] [Abstract][Full Text] [Related]
96. Transforming growth factor-β stimulates human ovarian cancer cell migration by up-regulating connexin43 expression via Smad2/3 signaling.
Qiu X; Cheng JC; Zhao J; Chang HM; Leung PC
Cell Signal; 2015 Oct; 27(10):1956-62. PubMed ID: 26186970
[TBL] [Abstract][Full Text] [Related]
97. Oncogenic MNK signalling regulates the metastasis suppressor NDRG1.
Tian S; Wang X; Proud CG
Oncotarget; 2017 Jul; 8(28):46121-46135. PubMed ID: 28545025
[TBL] [Abstract][Full Text] [Related]
98. Gene expression profiling reveals Ki-67 associated proliferation signature in human glioblastoma.
Jin Q; Zhang W; Qiu XG; Yan W; You G; Liu YW; Jiang T; Wang L
Chin Med J (Engl); 2011 Sep; 124(17):2584-8. PubMed ID: 22040407
[TBL] [Abstract][Full Text] [Related]
99. Candidate genes influencing sensitivity and resistance of human glioblastoma to Semustine.
Zhao Z; Liu Y; He H; Chen X; Chen J; Lu YC
Brain Res Bull; 2011 Oct; 86(3-4):189-94. PubMed ID: 21807073
[TBL] [Abstract][Full Text] [Related]
100. Attenuation of Smad2 activity shows resistance to TGF-β signalling in mammary adenocarcinoma (MCF-7) cells.
Sengupta S; Kundu S; Bhattacharyya A
Cell Biol Int; 2013 May; 37(5):449-57. PubMed ID: 23494890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]